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Cleft lip with or without an associated cleft palate (CL/P) is one of the most common 
congenital birth defects.  Both the frequency with which it occurs and the high psychosocial and 
financial costs associated with CL/P contribute to a significant public health interest in the 
condition.  Defining the spectrum of disability associated with CL/P will serve to improve 
treatment planning and caregiver education and may inform efforts to describe the etiology of 
this complex trait.    
The principal aim of this project was to test the hypothesis that significant olfactory 
dysfunction exists in individuals with repaired orofacial clefts (OFCs; cleft lip, with or without 
cleft palate ((CL/P) and isolated cleft palate (CP)) and their first degree relatives (FDRs).  Two 
small studies and anecdotal reports suggest impaired olfaction in individuals with OFCs, but this 
is the first investigation of the olfactory phenotype in both cases and relatives.   Genetic, 
physiologic, and developmental features of individuals with OFCs provide plausible 
explanations for this poorly explored phenomenon.  
Methods:  The widely used and extensively validated University of Pennsylvania Smell 
Identification Test (UPSIT) - a "scratch and sniff" 40 item odor discrimination test - was 
employed to describe olfactory ability in a sample of 12 subjects with non-syndromic CL/P or 
CP and 39 of their unaffected FDRs.  Control data was obtained from published norms on over 
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2000 individuals.  Standard non-parametric and categorical statistics were used to test for group 
differences in olfactory performance. 
Results:  The likelihood of having a smell deficit was increased nearly fivefold in the 
cases (OR=4.94; 95% CI 1.56-15.65) compared with controls. Similarly, the likelihood of having 
a smell deficit was increased nearly fourfold in the FDRs (OR=3.87; 95% CI 1.99-7.52) 
compared with controls.  Cases scored significantly lower on the UPSIT compared with their 
FDRs (p<0.043), indicating that the olfactory deficit was greater in cases. This study provides 
the first evidence of olfactory deficits in the FDRs of OFC cases and confirms the existence of 
olfactory deficits in OFC patients. 
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1.0  INTRODUCTION  
Little has been published about possible impairment of the sense of smell in individuals with 
non-syndromic cleft lip with or without cleft palate (CL/P) or isolated cleft palate (CP).  Genetic, 
physiologic, and neuroanatomic features of individuals with CL/P or CP provide plausible 
explanations for this under recognized phenomenon.  Neuroimaging studies, for example, have 
shown morphological abnormalities in the ventral frontal cortex of individuals with facial clefts, 
a brain region critical to the processing of olfactory information.  Additionally,  both orofacial 
clefts and anosmia (total inability to detect odor) are a major features of the genetic disorder 
Kallmann Syndrome. Finally, regardless of repair status considerable dysmorphology is likely to 
be present in the internal nasal architecture of those with OFCs; such changes can impact 
airflow, nasal volume, and airway dynamics, all of which can have a functional impact on 
olfaction.  Given that both OFCs and the associated corrective surgeries typically impact the 
nasal cavity, it is expected that olfaction will be either reduced (hyposmia) or absent (anosmia) in 
OFC individuals at higher rates than in the general population.   
Two previous studies as well as anecdotal evidence suggest that CL/P patients may have  
a diminished (hyposmia) or absent (anosmia) sense of smell.  In a study of 15 subjects (nine 
boys, six girls) with CL/P, Richman et al demonstrated a reduced ability to discriminate between 
odors in fully 50% of affected males, compared with only 9% of unaffected male controls 
(Richman et al. 1988).  There was no difference in odor discrimination ability between affected 
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and control females.  In a group of 25 patients, Grossmann et al (2005) obtained mixed results in 
olfactory assessment of CL/P subjects. This study detected reduced airflow and a higher 
threshold for odor detection in CL/P subjects, but in direct contrast to Richman and colleagues, 
found no evidence of difficulty with odor discrimination (Grossmann et al. 2005). It has been 
established by several groups (Fukushiro and Trindade 2005; Grossmann et al. 2005) that CL/P 
patients have changes in nasal airflow and total nasal cavity volume, including a reduction in  
both airflow and nasal volume on the cleft side in unilaterally affected (UCLP) subjects (Pirvola 
et al. 2002; Hebert et al. 2003).   Gross anatomic differences leading to reduced airflow are an 
attractive explanation for olfactory deficits but are likely to be overly simplistic given these 
mixed results.  
The results of several additional areas of inquiry provide insight into other possible 
underlying causes for olfactory dysfunction with OFC.  Kallmann Syndrome (KS), a genetic 
disorder characterized by facial clefting, anosmia and idiopathic hypogonadotropic 
hypogonadism, has causative FGFR1 mutations in common with non-syndromic (NS) CL/P.  
Dodé and others (Dode et al. 2003; Murray and Schutte 2004) have noted that KS patients with 
FGFR1 mutations have a relatively high (~25%) prevalence of orofacial clefts, an intriguing 
overlap given the established role of FGFR1 in NS clefting (Riley et al. 2007; Riley and Murray 
2007). FGFR1 expression has also been shown to play an important role in olfactory bulb 
morphogenesis (Pirvola et al. 2002; Hebert et al. 2003; Dode et al. 2007). A further line of 
evidence implicates changes in brain structure.  Traumatic brain injury (TBI) experience 
confirms that damage to the ventral frontal cortex (VFC, containing the olfactory bulb) 
frequently results in a reduced ability to discriminate between odors (Yousem et al. 1999). 
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Intriguingly, Boes and Nopoulos  have discovered structural abnormalities in the ventral frontal 
cortex (VFC) in male CL/P patients (Nopoulos et al. 2005; Boes et al. 2007).   
The majority of evidence to date suggests that olfaction is in some way compromised in 
individuals with OFCs.  Various biologically plausible explanations exist.  Exploring each of 
these possible mechanisms was beyond the scope of this project. The goal of this project is to 
determine whether olfactory deficits are indeed part of the orofacial clefting phenotype.  Positive 
results in this inquiry are expected to lead to a more rigorous investigation of the underlying 
causes of reduced olfaction.  Given that a variety of subclinical phenotypes have been identified 
in the relatives of those with OFCs, we proposed that unaffected first degree relatives of OFC 
cases would also show some level of olfactory dysfunction.  This study marks the first time that 
these relatives have been assessed for the olfactory phenotype.  
Olfaction is of great importance in social, emotional, and environmental health.  If 
reduced olfactory ability is indeed a part of the orofacial cleft phenotype, it is deserving of 
attention in its own right given the negative consequences associated with smell problems.   
Of more academic interest is the ability of expanded phenotypes (often referred to as 
“subclinical phenotypes” because they may appear in individuals not visibly affected with an 
overt defect) to inform our search for candidate genes and improve estimation of recurrence 
risks.    With the recognition that clefting appears multiple times in some pedigrees, numerous 
centers around the world sought to discover the genetic basis for OFCs and to identify 
predisposing features in unaffected family members.  In the early 1960’s, Fukuhara and 
colleagues at Tokyo Medical and Dental University became interested in what they called a 
“carrier status” for cleft lip and palate.  Through a series (Fukuhara and Saito 1962; Fukuhara 
and Saito 1963; Fukuhara 1965) of radiographic studies, they discovered a variety of 
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abnormalities in the bony nasal structures, nasal septum, and palates of unaffected relatives of 
CL/P individuals.  Two-thirds of unaffected monozygotic twins of individuals with CL/P were 
found to have a reduction in nasal cavity width in a later study (Johnston and Hunter 1989); 
similar findings were described in affected individuals (Liu et al. 1992).  As previously 
discussed, the structure of the nasal cavity is of critical importance in olfaction.  This, along with 
previously described genetic contributions to both olfactory system development and palate 
morphogenesis, suggests that any olfactory deficits identified in OFC patients may extend to 
their visibly unaffected relatives.  
More recently, the Center for Craniofacial and Dental Genetics (CCDG) at the University 
of Pittsburgh in particular has had success in identifying several diverse subclinical phenotypes 
in family members of OFC patients (Weinberg et al. 2006) in numerous ethnic groups.  
Subclinical phenotypes described in relatives of CL/P patients by the CCDG and others include 
subepithelial defects in the orbicularis oris muscle (Klotz et al. 2010), whorls on the lower lip 
(Neiswanger et al. 2009), altered dermatoglyphic patterns (Neiswanger et al. 2002), an excess of 
non-right handedness (Scott et al. 2005), and a specific pattern of  facial proportions in the 
parents of children with OFCs (Weinberg et al. 2009). 
Identification of a new subclinical phenotype will aid in providing genetic counseling to 
families, improve treatment and management, and possibly lend power to genetic association 
studies in CL/P and CP populations.  The presence of familial morphologic changes and 
specifically the presence of familial changes in nasal cavity structure provided support to our 
hypothesis that olfactory deficits may in fact be a previously unrecognized subclinical feature of 
the non-syndromic orofacial cleft phenotype.  
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2.0  SPECIFIC AIMS 
2.1 SPECIFIC AIM 1 
Assess and compare odor discrimination ability in CL/P and CP cases using the 40-item 
University of Pennsylvania Smell Identification Test.  
Hypothesis relating to Aim 1.  Individuals with non-syndromic CL/P and CP will  
demonstrate deficits in odor discrimination compared with both published norms and unaffected 
relatives on the Smell Identification Test.   
2.2 SPECIFIC AIM 2 
Assess and compare odor discrimination ability in the unaffected relatives of CL/P or CP cases 
using the 40-item University of Pennsylvania Smell Identification Test.  
Hypothesis relating to Aim 2.  Unaffected relatives will demonstrate deficits in odor  
discrimination compared with published norms on the Smell Identification Test. 
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2.3 SPECIFIC AIM 3: 
Assess sex differences in odor discrimination among cases and unaffected relatives as compared 
with age-matched norms using the University of Pennsylvania Smell Identification Test.  
Hypothesis relating to Aim 3.   Compared with females, males affected with non-
syndromic CL/P and CP and their male unaffected relatives will show a greater reduction in 
ability to discriminate between odors compared with age and gender matched controls. 
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3.0  BACKGROUND AND SIGNIFICANCE 
3.1 CLEFT LIP AND PALATE 
3.1.1 Epidemiology  
Cleft lip, with or without cleft palate (CL/P) and cleft palate only (CP) may occur as an isolated 
birth defect or as part of a larger sequence or syndrome.  Only individuals with nonsyndromic 
(isolated) CL/P or CP were considered in the course of this study; all epidemiologic data 
therefore  refer to the isolated CL/P and CP population only.   Of the two conditions, CL/P is 
more common with CP occurring half to one-third as frequently (Spritz).  An estimated 70% 
(Spritz) of CL/P is of the non-syndromic variety, while between 15-50% of CP occurs in the 
absence of a syndrome or sequence (Croen et al. ; Spritz). 
Cleft lip and/or cleft palate are common, pan ethnic conditions.  A large study of over 
2,000 ethnically diverse CL/P and CP patients in California demonstrated an incidence of 1.5-2 
per 1,000 live births, with the incidence varying by population (Croen et al. 1998).  In this 
particular cohort, the prevalence of CL/P was highest among Native Americans, followed by 
Whites, Japanese, and Chinese and lowest in African Americans.  CP showed a similar 
distribution, with the highest rates in Native Americans followed by Whites, Hispanics, and 
African Americans.   
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3.1.2 Developmental origin of orofacial clefting 
It is useful to consider the normal progression of midface development in order to fully 
appreciate the developmental origin of OFCs.    At week 4 of embryonic development (Cohen 
2006) just after closure of the anterior neural tube, the foundation of future midface structures 
arises in the form of five prominences (Figure 1) or swellings: a single frontonasal prominence 
and paired bilateral maxillary and mandibular prominences (Bender).  These structures originate 
from migrated neural crest cells.   
 
Figure 1: Facial Features of Embryoi  
 
 
Later in the fourth week, the mandibular prominences merge to form the lower jaw 
(mandible), lower lip, and lower cheeks while the maxillary prominences continue to grow 
towards each other.  By week 6-7, nasal pits from nasal placodes surrounded by the frontonasal 
swellings have formed nasal pits (later the nares) and the medial (inner) portions of the 
frontonasal prominence have fused with each other and with the maxillary prominences, giving 
rise to the upper lip.  This allows for development of the intermaxillary segment, which will form 
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the small primary palate, philtrum, and dental arch.   During this same time, shelf-like structures 
extend from the maxillary process then merge following programmed cell death and subsequent 
fusion along the advancing edges.  These shelves form the secondary palate, which comprises the 
majority of the adult hard palate.  Each stage of this process requires carefully orchestrated 
bilateral symmetric cell migration, differentiation, growth, and apoptosis to allow for the 
complete fusion of homologous structures into single unified midface structures. Numerous 
proteins are involved in this complex process.  Of particular note to this investigation, FGFR1 
participates in apoptosis at the medial edge epithelium of the palatal shelves- a critical antecedent 
to the fusion of the bilateral shelves to form an intact hard palate; (Britto et al. 2002) the role of 
this protein in olfaction will be discussed in section 1.2.2.  An error in the control or execution of 
any part of this process can lead to failure of paired structures to unite and result in an orofacial 
cleft.  A variety of cleft configurations ranging from a slight unilateral cleft of the lip to a 
bilateral, completely open lip and palate are possible (Figure 2), depending on which processes 
are impacted (Cohen 2006 ; Mossey et al. 2009).  
 
 
Figure 2:  Non-syndromic orofacial cleftsii 
 A. Cleft lip and alveolus. B. Cleft palate. C. Incomplete unilateral cleft lip and palate.  
D. Complete unilateral cleft lip and palate. E. Complete bilateral cleft lip and palate. 
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3.2 OLFACTION 
 
3.2.1 Anatomic and molecular basis of olfaction 
Olfaction (the process of detecting and identifying odors) relies on processes in both the nasal 
cavity and the brain.  For the purposes of this study the primary process of interest is odor 
detection, which occurs in the nasal cavity and during the earliest stages of brain involvement.   
 The first stage in the process of olfaction is detection of an odorant.  In order for 
detection to occur, air containing volatile aromatic compounds must be taken in (inhaled) 
through the vestibule of the nose- that is, the area just inside the nostrils.  This area is divided by 
the nasal septum, which separates air intake from the left and right nostrils and supports the nasal 
cartilage (Sahin-Yilmaz and Naclerio).  Several components of the nasal architecture interact at 
this point to create individual variations in airflow volume and patterns.  Congenital differences 
such as thickness of the nasal cartilage or variations in septum or alae shape along with acquired 
factors such as congestion, polyps, and trauma all create subtle (or not so subtle) differences in 
the initial phase of olfaction (Pinto 2011).  
Once air has entered the nose, three bony structures called turbinates direct its flow  
through the remainder of the nasal cavity. Approximately 10% of all air inhaled through the nose 
is eventually directed to the olfactory region (Sahin-Yilmaz et al.) by these structures. The 
turbinates are described by their position relative to the vestibule and are referred to as the 
inferior, middle, and superior turbinates.  The uppermost (superior) and middle turbinate surfaces 
along with the roof of the nasal cavity and a small portion of the septum are comprised of 
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olfactory epithelium (Pinto 2011; Sahin-Yilmaz et al.).  In a unique projection of the nervous 
system into the environment, olfactory sensory neurons are present in this lining and receive 
direct stimulation from inhaled odor molecules (Hoover). The olfactory neurons project through 
the skull at the cribiform plate to the olfactory bulbs, paired structures located above the 
olfactory epithelium and just below the frontal lobe of the human brain (Hoover). As with any 
neuron, the basis of olfactory neuron function is the fitting of a stimulant molecule, in this case 
an odorant, with an appropriately shaped receptor located in the plasma membrane of the neuron 
(Hoover ; Pinto 2011). In the final stage of odor detection, the fitting of odorant to receptor 
triggers a biochemical response and subsequent nerve impulse, which in turn stimulates the 
olfactory bulb. 
   Each olfactory neuron expresses one just type of odorant receptor (OR); 10-20 million of 
these cells are required for discrimination of odors (Pinto).  It is likely that each odorant 
stimulates a unique and characteristic pattern of receptors rather than only a single receptor type 
(Holbrook and Leopold 2006). Reflective of this complexity is the large number of genes in the 
human genome responsible for the development of ORs; the OR gene family numbers 900 in 
humans and represents 3-5% of the entire genome (Baghai et al. ; Young and Trask), although it 
bears mentioning that over half of these genes have degenerated into pseudogenes (Young et al.).   
Within the olfactory bulb, the individual olfactory neuron axons converge into glomeruli  
representing one type or category of receptor (odorant), allowing for the efficient transduction of 
information to the olfactory cortex for processing (Figure 3). Several types of cells provide 
output from the olfactory bulbs, with mitral cells being the primary connection from the 
olfactory bulbs to the cortex (Reed 2004).  Information from the olfactory bulb is processed in a 
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complex fashion in the olfactory cortex of the cerebrum. It is at this stage of the process that 
detection ends and perception begins.  
The hypotheses tested in this project are suggested and supported by phenomena related 
to the detection phase of olfaction.  A thorough review  of perception is therefore beyond the 
scope of this project.  It is however interesting to note that perception of odors takes place in the 
limbic and paralimbic regions of the brain- the same regions involved in the processing of 
emotions and formation of memories.  Perhaps it is this connection which underlies the reported 
reduced quality of life in those who suffer from olfactory dysfunction (Smeets et al. 2009). 
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Figure 3 Schematic of connections in the olfactory bulbiii 
 
 
3.2.2 Prevalence of olfactory deficits in healthy populations 
Olfactory deficits are not unheard of in the general population, whether they are congenital or the 
result of facial trauma, inflammation of the oral mucosa, polyps, or structural abnormalities.  
Formal investigations of this problem in otherwise healthy individuals are rare, but a population-
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based study (Bramerson et al. 2004) conducted by Brämerson and colleagues in Sweden 
suggested that 19.1% of healthy persons have some decrease in their ability to identify odors.  
The finding was somewhat stronger in males and older individuals as well as in people with 
nasal polyps or diabetes.  Smoking did not negatively impact olfactory ability, although other 
groups (Frye et al. 1990) have found a dose-dependant decrement in the odor identification 
ability of smokers.  The use of published, validated normative scores (Doty 2008) for 3,928 
healthy individuals by sex and age was used in this investigation in order to eliminate the 
possibility that any deficits detected in our sample were related to this apparently high 
prevalence of deficits in the population.   
 
3.3 FUNCTIONAL IMPORTANCE OF OLFACTION 
While it may appear at first glance to be a trivial or minor deficit, reduced olfactory ability in 
fact places a considerable burden on those affected.  Loss or reduction in the sense of smell 
interferes with environmental cues warning of fire, spoiled foods, dangerous chemicals, or 
noxious gasses.  Olfaction is also intrinsically linked to memory formation and learning (Walla 
2008) and plays a vital role in social and emotional exchanges (Zhou and Chen 2009). Smeets 
and colleagues found that anosmic and hyposmic patients experience significantly more 
depression and report an overall reduced quality of life compared with their peers (Smeets et al. 
2009).  One survey cited by Smeets (Smeets et al.) found that fully half of over 100 individuals 
with smell dysfunction would be willing to spend at least 20% of their annual income to correct 
the problem, indicating the large impact that loss of smell has on perceived quality of life.   
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 A recent investigation (Sobin et al. 2006) of olfactory deficits in children with 22q11 
deletion syndrome found significant deficits in the affected children compared with their healthy 
siblings.  Most striking were the results for individual odor discrimination.  Over half of the 
affected children failed to correctly identify the odor of smoke compared with fewer than 9% of 
their siblings.  These children also struggled (41% error rate) to identify paint thinner, considered 
by the authors to be a proxy for the larger category of toxic fumes.  These data support concerns 
that important safety hazards exist in children with olfactory dysfunction.  In addition to several 
other structural abnormalities, individuals with 22q11 frequently present with clefts of the 
secondary palate, lending additional support to the notion that cleft and olfaction may be related. 
Determination of any reduced olfactory ability CL/P patients experience provides an  
important target for psychosocial and patient education interventions aimed at improving patient 
safety and quality of life. 
3.4 PHYSIOLOGY OF OLFACTORY DYSFUNCTION 
3.4.1 Olfaction and nasal anatomy 
Adequate olfaction depends on structures in both the nasal passages and the brain.  Nasal 
turbinates direct odorant molecules to neurons embedded in the olfactory epithelium.  The 
olfactory neurons project to the olfactory bulb and converge into mitral-cell interfacing glomeruli 
in the olfactory bulb, allowing for the efficient transduction of information through the olfactory 
cortex for processing.  Nasal passage structure is also an important component of olfaction.   
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Unilateral obstructions have been shown to affect uninasal olfaction, although in general overall 
olfactory ability tends to reflect the ability of the higher-functioning nostril (Hornung and 
Leopold 1999). 
Several groups have examined the relationship between nasal structure, airflow, and  
olfaction in both cleft and typical populations.  Hornung and Leopold (1999) found relationships 
between the volume of some nasal compartments and olfactory ability, with larger posterior 
(upper nasal chamber) compartments and smaller volume at the nostril compartments being 
associated with satisfactory olfactory performance (Hornung et al. 1999). Interestingly, 
Fukushiro & Trindade observed that posterior rhinomanometry (PR) measurements in 16 UCLP 
subjects did not differ significantly from unaffected controls, although PR measures did differ in 
BCLP subjects (Fukushiro et al. 2005). These results can be contrasted with an evaluation of 
olfactory ability in CL/P by Richman et al (1988) in which more than half (57%) of boys with 
ULCP but no boys with BLCP performed poorly (<60% correct) on a ten-item odor 
discrimination test (Richman et al. 1988). The discordance been these results may be a function 
of small sample size or specific sample characteristics, but they may also indicate that some 
developmental process beyond simple disruption of normal nasal architecture is at work.   
More recently, Grossmann and colleagues detected significantly decreased nasal airflow  
in both UCLP and BLCP subjects but no difference in odor detection threshold in BLCP subjects 
as compared with controls.  Conversely, they did find a statistically significant correlation 
between reduced airflow and higher smell threshold in UCLP patients (Grossmann et al. 2005). 
This failure to demonstrate a consistent relationship between cleft type, nasal airflow, and smell 
threshold indicates that nasal airflow changes alone are not sufficient to explain the odor 
discrimination deficits found in CL/P populations.     
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Although mixed, these findings are of interest given the previously described 
morphologic changes in the family members of CL/P and CP individuals.  If anatomy-related 
changes in airflow are even partially responsible for differences in odor discrimination ability, it 
would be expected that anatomic differences in family members would lead to a similar olfactory 
phenotype in them.   
Establishing the true extent of the olfactory deficits in CL/P populations  will allow 
researchers to begin to interpret the results of nasal airflow studies and may eventually inform 
repair techniques that will best restore normal nasal anatomy. 
3.4.2 Brain structure, olfaction, and orofacial clefts 
Studies in traumatic brain injury (TBI) patients have confirmed the vital role of the olfactory 
bulb and olfactory tract in the detection of and discrimination between odors.  Multiple groups 
have demonstrated a correlation between decreased volume in the ventral frontal cortex (VFC), a 
region that includes the olfactory bulb, and poor scores on the University of Pennsylvania Smell 
Identification Test (SIT) (Yousem et al. 1999; Fujiwara et al. 2008).  It is clear from these works 
that structural integrity of the VFC is essential for satisfactory olfaction.   
Neuroimaging studies in CL/P populations have demonstrated a pattern of VFC  
abnormalities in affected males.  Specifically, they have revealed an overall decrease in 
orbitofrontal cortex (OFC) volume in CL/P adult males (Nopoulos et al. 2005) and a reduction in 
straight gyrus (a VFC structure) volume in a pediatric CL/P population (Boes et al. 2007) 
previously shown to have a variety of other morphologic brain abnormalities (Nopoulos et al. 
2007).  A recent study by van der Plas and colleagues revealed that boys with right-sided cleft lip 
have global reductions in white matter volume (van der Plas et al.).  The volume reductions were 
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most striking in the cerebrum, particularly in the occipital and frontal lobes.  While the olfactory 
bulb was not specifically mentioned, the proximity of the olfactory bulb to the regions shown to 
be reduced in size as well as the overall effects in the cerebrum (site of higher-level odor 
processing) is an interesting possible contributor to olfactory deficits. 
Taken together, the TBI and CL/P neuroimaging literature suggest the presence in of  
significant structural brain abnormalities in regions likely to affect olfaction in individuals with 
CL/P. 
 More work is necessary to understand the association between these abnormalities, 
OFCs, and olfaction and to determine whether similar changes are present in family members of 
those with OFCs.  
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4.0  SPECULATIVE GENETIC CONTRIBUTIONS TO ANOSMIA IN OFC 
4.1.1 Developmental origins of olfaction 
Of special relevance to any investigation of olfaction in OFC populations is the critical role 
played by FGFR1 in the development of the olfactory system.  This gene, also implicated in 
orofacial clefting, is critical for morphogenesis of the olfactory bulbs (Riley et al.).  Hebért et al  
demonstrated in 2003 that mouse embryos without functional Fgfr1 do not develop a working 
olfactory bulb (Hebert et al. 2003).  Dodé (Dode et al. 2007) and Pitteloud (Pitteloud et al. 2006) 
then demonstrated that FGFR1 expression is similarly essential for olfactory bulb morphogenesis 
in humans. 
A genetic condition called Kallmann Syndrome (KS) will be discussed in more detail in 
section 4.1.2 of this document.  Briefly, these individuals have hypogonadism with anosmia.  
Based on the discovery that some cases of KS are caused by mutations in anosmin-1 encoding 
KAL1, Hardelin and colleagues conducted a series of immunohistofluorescence experiments on 
human embryos and confirmed that anosmin-1 is an essential component of olfactory bulb 
development.  Later investigations described positive regulation of FGFR1 by anosmin-1, 
confirming the primary role for both of these proteins in the development of functional olfactory 
bulbs (Ayari and Soussi-Yanicostas 2007; Hu et al. 2009).  
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Outside of the olfactory bulb, the olfactory sensory neurons play a critical role in 
olfaction.  Sonic hedgehog (SHH), a gene widely implicated in a broad phenotypic spectrum of 
craniofacial abnormalities including OFCs, has additionally been shown to play a critical role in 
olfactory sensory neuron functioning (Lipinski et al. ; Hu and Helms 1999; Jiang et al. 2006).  
Gong et al recently found that Shh is involved in olfactory axon growth, branching, and 
glomerular interfacing in mice (Gong et al. 2009).  When Shh was blocked, olfactory neuron 
axons were immature and failed to project into the glomeruli, despite the fact that the structural 
integrity of the olfactory bulb and glomeruli was preserved.   
 While the present study is not able to assess the relative contribution of any of these 
genes to smell deficits in OFC populations, defining the olfactory phenotype in cases and 
relatives is a first step in designing experiments designed to do so. 
4.1.2 Syndromic occurrence of anosmia and CL/P 
FGFR1 has a role in ~3-5% of NS CL/P cases (Murray 2004).  Kallmann syndrome (KS), 
a genetic disorder characterized by anosmia in the presence of idiopathic hypogonadotropic 
hypogonadism, has causative FGFR1 mutations in common with non-syndromic (NS) CL/P.  KS 
may be inherited in an autosomal dominant (Kallmann syndrome 2, KS2) or X-linked (KS1) 
manner. Kallmann syndrome 1 is caused by mutations in KAL1, whereas KS2 results from 
mutations in FGFR1. Together KS1 and KS2 account for only ~25% of patients (Pallais et al. 
2007); additional clarification regarding the genetic status of other patients is needed. The 
olfactory deficits present in KS1 and KS2 patients result from both KAL1 (anosmin-1 encoding) 
mutations and from FGFR1 mutations.  This overlap is explained by the fact that anosmin-1, 
crucial for olfactory bulb development in embryos, (Hardelin et al. 1999) is known to act as a 
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regulator of FGF signaling (Ayari et al. 2007). Accordingly, KS patients with an anosmin-1 
(KAL1) mutation have a failure of olfactory bulb morphogenesis secondary to altered anosmin-
FGF interaction, while KS2 patients have FGF deficiencies which lead to failed olfactory bulb 
morphogenesis despite the presence of normal anosmin-1.   
Orofacial clefting occurs in about 5% of all KS patients, much higher than the population 
prevalence of 0.12%.   Compared with the larger KS population, KS patients with FGFR1 
mutations (KS2) have a relatively high (25-30%) prevalence of orofacial clefts, (Dode et al. 
2003; Albuisson et al. 2005; Dode et al. 2007) an intriguing overlap given the established role of 
FGFR1 in non-syndromic clefting (Riley et al. 2007; Riley et al. 2007).  In addition to overt 
clefts, KS patients frequently have other midline facial defects including high-arched palate and 
dental agenesis.  Palatal form changes, CL/P, and dental agenesis have also been reported in KS 
patients with KAL1 (anosmin-1) and unidentified mutations, although to a lesser degree than in 
KS2 patients (Versiani et al. 2007). Interestingly, at least one study of KS patients has identified 
a family history of hyposmia and/or anosmia (in 8 families of 10 patients) in family members 
without an overt KS phenotype, suggesting reduced penetrance and variable expressivity for 
these mutations (Versiani et al. 2007).   
 The Kallmann syndrome population provides intriguing insight into the shared genetic 
pathways for olfactory system and craniofacial development.  Identifying those families with 
olfactory deficits as part of the phenotypic spectrum of OFCs may lend additional power to 
candidate gene studies in the future.   
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5.0  MATERIALS AND METHODS 
5.1 THE UNIVERSITY OF PENNSYLVANIA SMELL IDENTIFICATION TEST 
The University of Pennsylvania Smell Identification Test (UPSIT or SIT) is an 
extensively validated 40 item forced-choice test designed to evaluate odor discrimination ability 
in subjects as young as 5 years of age (Doty et al. 1984). The test consists of four booklets 
containing 10 odorants each, with one odorant challenge per page.  Each odorant is embedded in 
microcapsules and released only upon scratching with a pencil tip.  A multiple choice question 
with four possible answers is presented with the odor, for example “This odor smells most like a) 
chocolate b) banana c) onion or d) fruit punch” (Doty et al. 1984). 
An odor identification test was chosen over smell threshold detection tests for several 
reasons.  First is the ease of administration; the test is durable, relatively easy for staff to learn 
and administer consistently, and can be completed in a small amount of time as part of a larger 
protocol.  In addition to ease of use, forced-choice odor identification is known to be as effective 
as more burdensome threshold tests in detecting olfactory deficits (Richman et al. 1988).  Given 
that at least some evidence for reduced odor discrimination exists while the evidence for 
increased smell threshold in CL/P populations is mixed at best, it was determined that the SIT 
discrimination test would be most informative for the purposes of this study.   
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5.2 DATA COLLECTION 
5.2.1 Recruitment  
5.2.1.1 Subject ascertainment  
Our goal was to enroll 50 CL/P individuals and 50 unaffected family members through 
recontacting of previous Center for Craniofacial and Dental Genetics (CCDG, University of 
Pittsburgh) study participants and a large, multi-day “research blitz” at The Children’s Hospital 
in Denver. CL/P subject status included bilateral and unilateral cleft lip, with or without cleft 
palate, as well as isolated cleft palate.  Only non-syndromic individuals were recruited.   
 Pittsburgh subjects were recruited via mailings to previous participating families with at 
least one eligible member as determined by a CCDG database query.  Additionally, families 
participating in the overall CCDG Orofacial Cleft Study completed the UPSIT protocol.  
Colorado families were recruited by the craniofacial clinic staff at The Children’s Hospital in 
Denver. 
5.2.1.2 Screening procedures 
Subjects at the University of Pittsburgh underwent phone screening prior to scheduling a study 
appointment.  This screening determined eligibility based on age, personal or family history of 
non-syndromic CL/P or CP, and absence of exclusion criteria discussed below.  These subjects 
underwent an additional round of on-site screening on the day of the study to verify the absence 
of exclusion factors (for example, the subject having developed rhinitis following the phone 
screen). 
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 Subjects at The Children’s Hospital in Denver were recruited and screened as part of a 
larger research study of which the smell test was a small portion.  These subjects were screened 
on-site for appropriateness, again based on age, affected status, and absence of any exclusion 
criteria.  This was accomplished by administering the questions included on the back of booklet 
one of the UPSIT test kit. 
5.2.1.3     Inclusion/Exclusion Criteria  
In order to be included in this study, subjects: (1) were 10-59 years old, (2) had a personal or 
family history (first degree relative) of non-syndromic (isolated) cleft lip with or without cleft 
palate or cleft palate only, (3) had no history of facial or head trauma, (4) had no current rhinitis, 
allergies, or upper respiratory infection, and (5) could not have a family history of syndromic 
orofacial clefts.  Males and females were included in the study.  Subjects of all ethnicities were 
eligible provided they spoke English or Spanish, the two languages available as validated forms 
of the UPSIT tool.   
5.2.2 Data collection procedures 
All recruitment and data collection procedures were conducted with the prior approval of the 
University of Pittsburgh Institutional Review Board (IRB) and the Colorado Multiple 
Institutional Review Board (COMIRB). 
 The UPSIT is widely used in both academic and clinical settings to test olfactory 
function.(Doty et al. 1995) The UPSIT has been extensively validated, provides age-adjusted 
normosmic, hyposmic, and anosmic scores, and shows high test-retest reliability.(Doty et al. 
1995) It consists of a 40-item, forced-choice odor identification test and is designed to detect 
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reduced ability to discriminate between familiar odors at normal concentrations.  Each odor is 
presented on a “scratch and sniff” style card with a four answer, multiple-choice question 
requiring the subject to select the odor being presented.  The expected time required to complete 
this test is 20 minutes.  Prior to administering each test, Pittsburgh subjects completed the 
“Olfaction On-Site Interview Form” to ensure eligibility.  Pittsburgh subjects did not complete 
the screening questions provided on the test booklets because identical information was collected 
elsewhere.  Denver subjects completed the screening questions provided with the test.  
Instructions were given as described in the test manual.  Subjects were instructed to sit apart 
from family members in an odorless room and were only permitted to address questions to the 
administrator.  A list of standard prompts or definitions was developed at the Center for 
Craniofacial and Dental Genetics (CCDG) by a multidisciplinary team of staff experienced in 
administering the test to children; only prompts from this list were used to answer questions from 
subjects in order to prevent the introduction of bias from multiple administrators.   
Following administration of the test, Pittsburgh subjects completed a short demographic 
form intended to capture information usually collected on the test booklet; this was done to allow 
the information to be collected on a scanable Teleform rather than on the test booklet.  As several 
years had elapsed since many of these subjects had been seen at the CCDG, the demographic 
form also contained questions regarding items which may be expected to change over time such 
as family history, smoking and medication status.  This step was not necessary for the Denver 
subjects because all data was collected at the time of UPSIT administration as part of the larger 
protocol.   
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5.3 SAMPLE CHARACTERISTICS 
A total of 58 subjects completed the protocol.   Five unaffected siblings and one grandparent 
were excluded from the final analysis for a total of 51 analyzed subjects from 25 families (12 
cases and 39 relatives).  The unaffected relative group was comprised entirely of the parents of 
affected children.  Three affected siblings from one family (Figure 4) were included in the 
analysis.  This interesting family was comprised of two sets of twins, one monozygotic and one 
dizygotic, as well as a singleton child.   The monozygotic twins did not take the UPSIT due to 
young age.   
 
Figure 4. Family with affected hyposmic twins 
* indicates UPSIT was administered to subject 
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Controls were not collected.   Nearly 4,000 healthy individuals have completed the 
UPSIT in the process of validating the test and developing normative scores; these data are 
available in the UPSIT test manual (Doty 2008) provided with the purchase of UPSIT test 
booklets.  Normative UPSIT data were available for 2762 individuals between the ages of 10 and 
59 (males, n = 1302; females, n = 1460).  The term “controls” is used here in reference to data 
derived from this population.   
 
 
 
 
 
 
 
Table 1 Group demographic composition 
 
Parameter Orofacial cleft First-degree relative 
N 12 39 
Gender (female/male) 4F/8M 24F/15M 
Ethnicity  
(Hispanic/Non -Hispanic) 
1H/11N 14H/25N 
Smoking 
        (self/household/no) 
0/2/10 14/13/12 
Primary Language  
(Spanish/English) 
0/12 9/30 
        Age  
        (years) 
18.6  ± 13.8 33.4 ± 7.7 
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5.4 DATA ANALYSIS 
Tests were scored by two independent raters using a template provided with the UPSIT test; 
incongruent results were reconciled by having both raters re-score the test. Consensus was easily 
reached with this method.  Briefly, subjects indicate their answer by filling in a bubble 
corresponding to their selection for each of 40 items.  A scoring template with only the correct 
answer bubble punched out is provided.  Scoring is completed by placing the template over the 
subject’s answer sheet and manually counting the number of missed items.  
The UPSIT is scored by comparing the subject’s number correct (out of 40 items) to the 
performance of age and sex matched controls.  The version of the test kit used for this project 
offered 1,302 male and 1,460 female controls for subjects in the 10-59 age range.  Controls are 
divided first by gender and then into groups spanning five years (i.e., males 5-9 years of age) and 
the percentile rank for each possible score is provided within these groups.  Clinical categories 
consist of normosmia, mild microsomia, moderate microsomia, severe microsmia, anosmia, and 
malingering and are determined based on the distribution of scores within each gender/age 
subcategory, allowing for subjects of different ages and genders to be compared with each other.   
For our sample, each subject was compared with the appropriate gender/age subcategory and 
assigned a status of “normosmic” for all subjects scoring in the normosmic clinical range or 
“deficit” for those subjects scoring in any of the remaining clinical categories.   
Statistical analysis was somewhat limited by the small number of OFC cases in the 
sample. Chi-square tests were used to compare the proportion of deficit in unaffected relatives to 
control norms.   The more conservative Fisher’s exact test was used to compare OFC cases with 
control norms and to compare male and female first degree relatives (FDRs) with each other and 
with control norms due to the small number of subjects in each category.  Results of the chi-
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square analyses were verified using the Z-ratio independent proportions test. Odds ratios were 
calculated for each of these comparisons. The Mann-Whitney U nonparametric test was used to 
rank and compare the raw UPSIT scores of FDRs with OFC cases and to compare the raw 
UPSIT scores of female and male FDRs.  All results were considered statistically significant if p-
values were at or below 0.05 and were reported as one-tailed values. 
Among cases and FDRs who either smoked or were exposed to household smoke, the 
number of subjects identified with and without an olfactory deficit was roughly equal (Table 2). 
Due to the similar distribution of smoking in each group and a lack of information regarding the 
smoking status of the UPSIT control population, smoking was not used as a variable in any 
analyses. 
 
Table 2: Summary of smoking rates 
 
Group Exposure Total (n) Deficit (n) 
OFC Household 2 1 (50%) 
 Smokers  0 0 
FDR Household 4 2 (50%) 
 Smokers 13 6 (46%) 
Total (OFC + FDR) Household 6 3 (50%) 
  Smokers 13 6 (46%) 
 
None of the study participants admitted to having bipolar disorder, schizophrenia, major 
depressive disorder or alcoholism, all of which are known to affect or be associated with changes 
in olfaction.  None of the participants reported taking any medications known to affect olfaction. 
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6.0  RESULTS 
6.1 SPECIFIC AIM 1 
Individuals with OFCs demonstrated a higher frequency of deficits in olfactory discrimination 
compared with both matched controls and unaffected first degree relatives (FDRs) on the Smell 
Identification Test. 
Of the 2,762 controls provided, 349 were classified as having some level of olfactory 
deficit.  The frequency of olfactory deficits was significantly higher in the 12 OFC cases, with 
five achieving scores in the deficit range (41.7% vs. 12.6%; p = 0.012).  The likelihood of having 
a smell deficit was increased nearly fivefold in the cases (OR = 4.94; 95% CI: 1.56-15.65) 
compared with controls.  These results are presented in Table 3. 
Subjects with OFCs also performed significantly worse on the UPSIT test than did their 
unaffected first-degree relatives.  The median case scores was 33.5 compared with 35 for FDRs 
(p = 0.043), indicating overall poor performance for the cases even compared with the deficit-
prone FDR group.  These results are presented in Table  4. 
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Table 3:  Comparison of olfactory deficits in cases vs controls 
 Cases (n=12) Controls (n=2762) p1-p2 (95% CI) Z p 
Deficit 5 (41.7%) 349 (12.6%) 0.29 (0.04-0.59) 3.008 0.001 
No Deficit 7 2413    
      
 χ2 = 9.045; df = 1; p = 0.012 (one-tailed) 
 OR (95% CI) = 4.94 (1.56-15.65) 
 
Table 4: Comparison of UPSIT scores between cases and unaffected first-degree relatives 
Cases (n = 12) Relatives (n = 39)   
Median Score Mean Rank Median Score Mean Rank U p 
33.5 19.58 35 27.97 157.000 0.043 
 
6.2 SPECIFIC AIM 2 
As hypothesized, unaffected first-degree relatives of OFC cases demonstrated a higher frequency 
of deficits in odor discrimination as compared with matched controls on the Smell Identification 
Test.  These results are presented in Table 5. 
The sample included 39 unaffected FDRs, 14 of whom were classified as having some 
level of olfactory deficit.  The frequency of olfactory deficits was significantly higher in the 
relatives than in the control population (35.9% vs. 12.6%; p < 0.001; one-tailed test).  The 
likelihood of having a smell deficit was increased nearly fourfold in the FDRs (OR = 3.87; 95% 
CI: 1.99-7.52) compared with controls. 
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Table 5: Comparison of olfactory deficit rates in first-degree relatives vs controls 
 
 
 Relatives 
(n=39) 
Controls 
(n=2762) 
p1-p2 (95% 
CI) 
Z p 
Deficit 14 (35.9%) 349 (12.6%) 0.23 (0.09-
0.40) 
4.295 < 0.001 
No Deficit 25 2413    
      
 χ2 = 16.443; df = 1; p < 0.001 (one-tailed) 
 OR (95% CI) = 3.87 (1.99-7.52) 
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NOR: Normal controls 
FDR: First-degree relative  
* p = 0.012 for OFC vs. NOR 
** p < 0.001 for FDR vs. NOR  
 
NOR: Normal controls 
FDR: First-degree relative  
* p = 0.018; male NOR vs. male FDR 
**p = 0.002; female NOR vs. female FDR 
 
Figure 5. Prevalence of olfactory deficits in all groups Figure 6. Prevalence of olfactory deficit by sex 
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6.3 SPECIFIC AIM 3 
A small case sample prevented direct testing of the hypothesis that males with OFCs have a 
greater magnitude of olfactory deficits than do females with OFCs.  The deficits found in male 
versus female FDRs was used as a proxy for this comparison.   
 When compared with control norms, male FDRs demonstrated a significantly higher 
frequency of smell deficits (Figure 8).  The control population offered 1,302 healthy males, 197 
of whom were classified as having some level of smell deficit.  Of the 15 male FDRs who 
completed the UPSIT, 6 scored in the deficit range.  The difference between these frequencies 
indicated a significantly higher prevalence of smell deficits in the male FDRs (40.0% vs. 15.1%; 
p = 0.018).  Male FDRs were almost four times more likely to have a smell deficit than were 
male controls (OR = 3.74; 95% CI: 1.32-10.62).  These results are presented in Table 6. 
Female FDRs showed a similar effect to male FDRs (Figure 8).  Of the 24 female FDRs 
completing the UPSIT, 8 (33.3%) had a deficit.  This was significantly higher than observed in 
the female control population of 1,460 of which 152 (10.4%) had a deficit (p = 0.002).  The 
likelihood for female FDRs to have a smell deficit was over fourfold higher than for female 
controls (OR = 4.30; 95% CI: 1.81-10.22).  These results are presented in Table 7.  
Finally, female FDRs were compared with male FDRs.  Contrary to the hypothesis that 
smell deficits would be more prevalent in males, these two groups showed similarly high rates of 
olfactory deficits.  There was a slight but statistically insignificant increase in the frequency of 
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smell deficits in male vs. female FDRs (40.0% vs. 33.3%; χ2 = 0.178; df = 1; p < 0.466).  There 
was a small reduction in the median UPSIT scores for male vs. female FDRs, but this again 
failed to reach significance (; p = 0.066).  These results are presented in Table 8. 
 
Table 6: Comparison of olfactory deficit rates in male first-degree relatives and male 
controls 
 Relatives ( n=15) Controls (n=1302) p1-p2 (95% CI) Z p 
Deficit 6 (40%) 197 (15.1%) 0.25 (0.02-0.52) 2.652 0.004 
No Deficit 9 1105    
      
 χ2 = 7.035; df = 1; p = 0.018 (one-tailed) 
 OR (95% CI) = 3.74 (1.32-10.62) 
 
Table 7: Comparison of olfactory deficits in female first-degree relatives  and female 
controls 
 Relatives  
 (n= 24) 
Controls 
 (n=1460) 
p1-p2 (95% CI) Z p 
Deficit 8 (33.3%) 152 (10.4%) 0.23 (0.06-0.45) 3.591 < 0.001 
No 
Deficit 
16 1308    
      
 χ2 = 12.898; df = 1; p = 0.002 (one-tailed) 
 OR (95% CI) = 4.30 (1.81-10.22) 
 
Table 8: Comparison of UPSIT scores between male and female unaffected first-degree 
relatives 
Male Relatives (n = 15) Female Relatives (n = 24)   
Median Score Mean Rank Median Score Mean Rank U p 
34 16.53 36 22.17 128.000 0.066 
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7.0  DISCUSSION 
The results obtained by this study demonstrate a clear association between orofacial clefting and 
olfactory deficits.  The olfactory deficits first identified by Richman (Richman et al. 1988) in the 
OFC population were confirmed and expanded upon with an added comparison between 
unaffected first degree relatives (FDRs) and individuals with OFCs (cases).  Richman and 
colleagues detected deficits in 10/20 (50%) of cases while the current study detected a deficit in 
5/12 (41.7%) of cases.  These results stand in contrast to the somewhat equivocal findings 
obtained by Grossmann et al (Grossmann et al.), in which only deficits in odor detection 
threshold but not odor discrimination were detected.  It should be noted that neither group used a 
standardized olfactory assessment tool for their work; Richman utilized 10 “common” odors 
suggested by a previous work (Wright 1987; Richman et al. 1988), while Grossmann used only 
four odors (including water) deemed “common household odors” and selected by an undisclosed 
method. 
Perhaps the most striking result of the current work was the unequivocal presence of 
smell deficits in the FDRs.  A variety of subclinical phenotypes have been described in the 
unaffected relatives of those with OFCs (Neiswanger et al. 2002; Scott et al. 2005; Neiswanger 
et al. 2009; Weinberg et al. 2009; Klotz et al. 2010); the present study strongly suggests that 
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there is an additional, previously undescribed phenotype involving a compromised ability to 
discriminate between odors.  
Several explanations are possible for the presence of impaired olfaction in the OFC cleft 
population.  These include genetic, physiologic, and structural factors as well as the possibility 
that defects occur secondary to invasive restorative surgeries and other interventions.  The recent 
discovery of smell deficits in the 22q11 deletion syndrome population (Sobin et al.) led to 
speculation by the authors that medical procedures such as the insertion of nasogastric tubes and 
repair of the pharyngeal flap may lead to olfactory compromise.  The current findings in first 
degree relatives strongly suggest that there may be some effect beyond simple disruption of the 
gross anatomy or treatment-induced trauma mediating the smell deficits found in people with 
OFCs.   
With regards to the genetic, physiologic, and structural contributions to olfactory 
functioning, the current study provides only indirect insight into the complex interactions 
between these factors.  Given that FDRs show a magnitude of deficits nearly matching that 
observed in cases it seems likely that genetic factors at least partially explain the link between 
clefting and olfaction. The aforementioned studies demonstrating changes in the face shape and 
brain structure of FDRs make it difficult to speculate about a straightforward explanation such as 
a shared genetic pathway for olfactory development and clefting as opposed to a less direct 
heritable mechanism like subtle anatomic changes as the source of shared deficits. 
If larger studies find that smell deficits in parents indicate a predisposition towards 
orofacial clefting, evaluating functional olfaction in parents of an OFC-affected child may offer a 
cost-effective, simple, objective way to refine recurrence risks for future children.  
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The calculation of accurate, personalized recurrence risks is critical for genetic 
counseling purposes.  If the degree to which olfactory deficits segregate with  OFCs in multiplex 
families is well quantified,  administration of the UPSIT could serve as a rapid assessment of 
parents of an affected child who are seeking information about their future risks.  Olfactory 
assessment in this case could also be utilized in extended family, serving as a marker of a 
predisposition to having a child of their own with an orofacial cleft.  Even more promising is the 
possibility of developing a battery of assessments to evaluate the full spectrum of subclinical 
phenotypes in family members; this would give the most accurate recurrence risk provided that 
the degree to which each serves as a marker of liability to clefting is carefully quantified.    
Aside from speculation about the underlying cause of the family-wide olfactory 
dysfunction identified, the results of this study provide useful clinical information.  Identifying 
the possibility of olfactory compromise in OFC patients is a first step in reducing any associated 
morbidity.  For example, awareness that a child with a CL/P is at risk to struggle with identifying 
the odor of smoke may prompt recommendations that families increase the number of smoke 
detectors in their home and use extra caution when allowing their child to be at home 
unsupervised or begin to cook independently.  Caution should also be used with paints or 
chemicals producing noxious odors and persons with reduced olfaction should be trained to be 
vigilant about ventilation given that they may lack awareness of toxic or combustible fumes in 
their environment.  Psychosocial interventions such as extra attention to personal hygiene and 
grooming habits may reduce the anxiety around body odor cited by many anosmic individuals 
(Miwa et al. 2001). 
In conclusion, the present study confirms the presence of olfactory deficits in individuals 
with CL/P or CP at nearly a fivefold higher prevalence than in the general population.  
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Furthermore, this study suggests for the first time that these deficits are found in at least a third 
of unaffected first degree relatives of persons with an OFC.   
Given these findings, psychoeducational interventions for individuals with an OFC may 
need to evolve to include training in awareness of smoke, gasses, or other environmental 
hazards.  Families may appreciate counseling regarding some of the physical and emotional 
sequelae of olfactory dysfunction, including higher rates of depression, concern about personal 
hygiene, altered perception of food taste, and excessive anxiety about failure to detect dangerous 
odors (Miwa et al. 2001; Smeets et al. 2009).  These findings may also inform candidate gene 
studies, attempts to clarify inheritance patterns for OFCs, and refinement of recurrence risks in 
families.  Future studies to confirm and expand these results are the first step in this process.   
7.1 LIMITATIONS 
One limiting factor in our analysis was the lack of control data such as raw scores and exact ages 
at the individual level.  Only percentile rankings and clinical categorizations were possible for 
the controls, making direct comparison of UPSIT scores impossible.  
 The small size of the OFC-affected sample was another imitation of this study.  Too few 
cases were available to conduct a meaningful analysis of the relationship between factors such as 
cleft type, repair/surgical history, the spectrum of cleft types in a family, or the presence of other 
subclinical phenotypes and smell deficits.  Furthermore, too few parent-child duos were available 
to draw any conclusions about recurrence risk related to the absence or presence of smell deficits 
or to detect patterns of concordance or discordance for the olfactory phenotype within families.   
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The inclusion of multiple family members in one case raises the possibility that some 
other factor present in this family (heritable or otherwise) could be influencing the anosmia 
identified in multiple members.  Given the robust finding in the unaffected relative group as a 
whole, we think this is unlikely but it cannot be completely eliminated.  Again, a larger sample 
will allow for more aggressive exclusion of subjects while still maintaining an adequate sample 
size. 
Many of these limitations are addressed by the recent inclusion of the UPSIT protocol in 
the larger Center for Craniofacial and Dental Genetics Orofacial Cleft study.  Over time, enough 
cases will become available to allow for finer comparisons such as the aforementioned ones.   
 
7.2 FUTURE LINES OF INQUIRY 
Several interesting lines of inquiry remain to be pursued.  Of utmost interest would be obtaining 
magnetic resonance imaging (MRI) scans of the nasal cavity and olfactory bulbs of OFC cases 
and FDRs.  This would allow for direct testing of the hypothesis that structural alterations in the 
nasal cavity and/or of the olfactory bulbs are related to the observed dysfunction.  Nasal airflow 
analysis would be particularly helpful in such investigations. 
Also interesting would be genetic studies to determine whether OFC individuals with 
smell deficits are more likely to have mutations in FGFR1, SHH, or as-yet undetermined genes 
related to both clefting and olfaction.  Additional information about the genetic causes of 
Kallmann syndrome may provide candidate genes beyond FGFR1 and SHH.   
 41 
 
The emerging literature regarding changes in the three-dimensional facial structure of 
family members of OFC cases also provides fertile ground for future investigations.  It would be 
interesting to test whether a particular pattern of facial measurements is more or less associated 
with smell deficits in these families.   
Finally, an expanded population of individuals with CL/P or CP is essential to determine 
whether the type of cleft is related to olfaction; this would provide guidance for genetic 
counselors, occupational therapists, and cleft-craniofacial teams in counseling families and 
would potentially further refine the phenotypes of individual families, increasing the power of 
genetic association studies. 
 
 
 
 
 
 
 42 
 
BIBLIOGRAPHY 
 
Albuisson, J., C. Pecheux, et al. (2005). "Kallmann syndrome: 14 novel mutations in KAL1 and 
FGFR1 (KAL2)." Hum Mutat 25(1): 98-9. 
Ayari, B. and N. Soussi-Yanicostas (2007). "FGFR1 and anosmin-1 underlying genetically 
distinct forms of Kallmann syndrome are co-expressed and interact in olfactory bulbs." 
Dev Genes Evol 217(2): 169-75. 
Baghai, M., G. B. Thompson, et al. (2002). "Pheochromocytomas and paragangliomas in von 
Hippel-Lindau disease: a role for laparoscopic and cortical-sparing surgery." Arch Surg 
137(6): 682-8; discussion 688-9. 
Bender, P. L. (2000). "Genetics of cleft lip and palate." J Pediatr Nurs 15(4): 242-9. 
Berk, N. W. and M. L. Marazita (2002). Cost of cleft lip and palate: personal and societal 
implications. Cleft Lip & Palate: From Origin to Treatment. D. F. Wyszynski. New York, 
Oxford Universiy Press: 458-467. 
Boes, A. D., V. Murko, et al. (2007). "Social function in boys with cleft lip and palate: 
relationship to ventral frontal cortex morphology." Behav Brain Res 181(2): 224-31. 
Bramerson, A., L. Johansson, et al. (2004). "Prevalence of olfactory dysfunction: the skovde 
population-based study." Laryngoscope 114(4): 733-7. 
Britto, J. A., R. D. Evans, et al. (2002). "Toward pathogenesis of Apert cleft palate: FGF, FGFR, 
and TGF beta genes are differentially expressed in sequential stages of human palatal 
shelf fusion." Cleft Palate Craniofac J 39(3): 332-40. 
Cohen, M. M. J. (2006). Perspectives On The Face. New York, Oxford University Press. 
Croen, L. A., G. M. Shaw, et al. (1998). "Racial and ethnic variations in the prevalence of 
orofacial clefts in California, 1983-1992." Am J Med Genet 79(1): 42-7. 
Dode, C., C. Fouveaut, et al. (2007). "Novel FGFR1 sequence variants in Kallmann syndrome, 
and genetic evidence that the FGFR1c isoform is required in olfactory bulb and palate 
morphogenesis." Hum Mutat 28(1): 97-8. 
Dode, C., J. Levilliers, et al. (2003). "Loss-of-function mutations in FGFR1 cause autosomal 
dominant Kallmann syndrome." Nat Genet 33(4): 463-5. 
Doty, R. L. (2008). The Smell Identification Test Administration Manual: 3rd Edition. 
Philadelphia, Sensonsics, Inc. 
Doty, R. L., D. A. McKeown, et al. (1995). "A study of the test-retest reliability of ten olfactory 
tests." Chem Senses 20(6): 645-56. 
 43 
 
Doty, R. L., P. Shaman, et al. (1984). "Development of the University of Pennsylvania Smell 
Identification Test: a standardized microencapsulated test of olfactory function." Physiol 
Behav 32(3): 489-502. 
Frye, R. E., B. S. Schwartz, et al. (1990). "Dose-related effects of cigarette smoking on olfactory 
function." JAMA 263(9): 1233-6. 
Fujiwara, E., M. L. Schwartz, et al. (2008). "Ventral frontal cortex functions and quantified MRI 
in traumatic brain injury." Neuropsychologia 46(2): 461-74. 
Fukuhara, T. (1965). "New Method and Approach to the Genetics of Cleft Lip and Cleft Palate." 
J Dent Res 44: SUPPL:259-68. 
Fukuhara, T. and S. Saito (1962). "Genetic Consideration on the Dysplasia of the Nasopalatal 
Segments as a 'Formes Frustes' Radiologically Found in Parents of Cleft Children: A 
Preliminary Report." Jap. Jour. Human Genet. 7(4): 5. 
Fukuhara, T. and S. Saito (1963). "Possible Carrier Status of Hereditary Cleft Palate WIth Cleft 
Lip; Report of Cases." Bull Tokyo Med Dent Univ  10:333–345 10: 13. 
Fukushiro, A. P. and I. E. Trindade (2005). "Nasal airway dimensions of adults with cleft lip and 
palate: differences among cleft types." Cleft Palate Craniofac J 42(4): 396-402. 
Gong, Q., H. Chen, et al. (2009). "Olfactory sensory axon growth and branching is influenced by 
sonic hedgehog." Dev Dyn 238(7): 1768-76. 
Grossmann, N., I. Brin, et al. (2005). "Nasal airflow and olfactory function after the repair of 
cleft palate (with and without cleft lip)." Oral Surg Oral Med Oral Pathol Oral Radiol 
Endod 100(5): 539-44. 
Hardelin, J. P., A. K. Julliard, et al. (1999). "Anosmin-1 is a regionally restricted component of 
basement membranes and interstitial matrices during organogenesis: implications for the 
developmental anomalies of X chromosome-linked Kallmann syndrome." Dev Dyn 
215(1): 26-44. 
Hebert, J. M., M. Lin, et al. (2003). "FGF signaling through FGFR1 is required for olfactory bulb 
morphogenesis." Development 130(6): 1101-11. 
Holbrook, E. H. and D. A. Leopold (2006). "An updated review of clinical olfaction." Curr Opin 
Otolaryngol Head Neck Surg 14(1): 23-8. 
Hoover, K. C. "Smell with inspiration: the evolutionary significance of olfaction." Am J Phys 
Anthropol 143 Suppl 51: 63-74. 
Hornung, D. E. and D. A. Leopold (1999). "Relationship between uninasal anatomy and uninasal 
olfactory ability." Arch Otolaryngol Head Neck Surg 125(1): 53-8. 
Hu, D. and J. A. Helms (1999). "The role of sonic hedgehog in normal and abnormal craniofacial 
morphogenesis." Development 126(21): 4873-84. 
Hu, Y., S. E. Guimond, et al. (2009). "Novel mechanisms of fibroblast growth factor receptor 1 
regulation by extracellular matrix protein anosmin-1." J Biol Chem 284(43): 29905-20. 
Jiang, R., J. O. Bush, et al. (2006). "Development of the upper lip: morphogenetic and molecular 
mechanisms." Dev Dyn 235(5): 1152-66. 
Johnston, M. and W. Hunter (1989). "Cephalometric analysis of monozygotic twins discordant 
for cleft lip/palate." J Dent Res 68. 
Klotz, C. M., X. Wang, et al. (2010)). "Revisiting the recurrence risk of nonsyndromic cleft lip 
with or without cleft palate." Am J Med Genet A 152A(11): 2697-702. 
 44 
 
Lipinski, R. J., C. Song, et al. "Cleft lip and palate results from Hedgehog signaling antagonism 
in the mouse: Phenotypic characterization and clinical implications." Birth Defects Res A 
Clin Mol Teratol 88(4): 232-40. 
Liu, H., D. W. Warren, et al. (1992). "Is nasal airway size a marker for susceptibility toward 
clefting?" Cleft Palate Craniofac J 29(4): 336-9. 
Miwa, T., M. Furukawa, et al. (2001). "Impact of olfactory impairment on quality of life and 
disability." Arch Otolaryngol Head Neck Surg 127(5): 497-503. 
Mossey, P. A., J. Little, et al. (2009). "Cleft lip and palate." Lancet 374(9703): 1773-85. 
Murray, J. C. and B. C. Schutte (2004). "Cleft palate: players, pathways, and pursuits." J Clin 
Invest 113(12): 1676-8. 
Neiswanger, K., K. W. Chirigos, et al. (2009). "Whorl patterns on the lower lip are associated 
with nonsyndromic cleft lip with or without cleft palate." Am J Med Genet A 149A(12): 
2673-9. 
Neiswanger, K., M. E. Cooper, et al. (2002). "Cleft lip with or without cleft palate and 
dermatoglyphic asymmetry: evaluation of a Chinese population." Orthod Craniofac Res 
5(3): 140-6. 
Nopoulos, P., I. Choe, et al. (2005). "Ventral frontal cortex morphology in adult males with 
isolated orofacial clefts: relationship to abnormalities in social function." Cleft Palate 
Craniofac J 42(2): 138-44. 
Nopoulos, P., D. R. Langbehn, et al. (2007). "Abnormal brain structure in children with isolated 
clefts of the lip or palate." Arch Pediatr Adolesc Med 161(8): 753-8. 
Pallais, J. C., M. Caudill, et al. (2007). Kallmann Syndrome. GeneReview. Seattle, University of 
Washington. 
Pinto, J. M. (2011). "Olfaction." Proc Am Thorac Soc 8(1): 46-52. 
Pirvola, U., J. Ylikoski, et al. (2002). "FGFR1 is required for the development of the auditory 
sensory epithelium." Neuron 35(4): 671-80. 
Pitteloud, N., J. S. Acierno, Jr., et al. (2006). "Mutations in fibroblast growth factor receptor 1 
cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic 
hypogonadism." Proc Natl Acad Sci U S A 103(16): 6281-6. 
Reed, R. R. (2004). "After the holy grail: establishing a molecular basis for Mammalian 
olfaction." Cell 116(2): 329-36. 
Richman, R. A., P. R. Sheehe, et al. (1988). "Olfactory deficits in boys with cleft palate." 
Pediatrics 82(6): 840-4. 
Riley, B. M., M. A. Mansilla, et al. (2007). "Impaired FGF signaling contributes to cleft lip and 
palate." Proc Natl Acad Sci U S A 104(11): 4512-7. 
Riley, B. M. and J. C. Murray (2007). "Sequence evaluation of FGF and FGFR gene conserved 
non-coding elements in non-syndromic cleft lip and palate cases." Am J Med Genet A 
143A(24): 3228-34. 
Sahin-Yilmaz, A. and R. M. Naclerio (2011). "Anatomy and physiology of the upper airway." 
Proc Am Thorac Soc 8(1): 31-9. 
Scott, N. M., S. M. Weinberg, et al. (2005). "Hair whorls and handedness: informative 
phenotypic markers in nonsyndromic cleft lip with or without cleft palate (NS CL/P) 
cases and their unaffected relatives." Am J Med Genet A 136(2): 158-61. 
Smeets, M. A., M. G. Veldhuizen, et al. (2009). "Sense of smell disorder and health-related 
quality of life." Rehabil Psychol 54(4): 404-12. 
 45 
 
Sobin, C., K. Kiley-Brabeck, et al. (2006). "Olfactory disorder in children with 22q11 deletion 
syndrome." Pediatrics 118(3): e697-703. 
Spritz, R. A. (2001). "The genetics and epigenetics of orofacial clefts." Curr Opin Pediatr 13(6): 
556-60. 
van der Plas, E., A. Conrad, et al. "Effects of unilateral clefts on brain structure." Arch Pediatr 
Adolesc Med 164(8): 763-8. 
Versiani, B. R., E. Trarbach, et al. (2007). "Clinical assessment and molecular analysis of 
GnRHR and KAL1 genes in males with idiopathic hypogonadotrophic hypogonadism." 
Clin Endocrinol (Oxf) 66(2): 173-9. 
Walla, P. (2008). "Olfaction and its dynamic influence on word and face processing: cross-modal 
integration." Prog Neurobiol 84(2): 192-209. 
Weinberg, S. M., S. D. Naidoo, et al. (2009). "Face shape of unaffected parents with cleft 
affected offspring: combining three-dimensional surface imaging and geometric 
morphometrics." Orthod Craniofac Res 12(4): 271-81. 
Weinberg, S. M., K. Neiswanger, et al. (2006). "The Pittsburgh Oral-Facial Cleft study: 
expanding the cleft phenotype. Background and justification." Cleft Palate Craniofac J 
43(1): 7-20. 
Wright, H. N. (1987). "Characterization of olfactory dysfunction." Arch Otolaryngol Head Neck 
Surg 113(2): 163-8. 
Young, J. M. and B. J. Trask (2002). "The sense of smell: genomics of vertebrate odorant 
receptors." Hum Mol Genet 11(10): 1153-60. 
Yousem, D. M., R. J. Geckle, et al. (1999). "Posttraumatic smell loss: relationship of 
psychophysical tests and volumes of the olfactory bulbs and tracts and the temporal 
lobes." Acad Radiol 6(5): 264-72. 
Zhou, W. and D. Chen (2009). "Sociochemosensory and emotional functions: behavioral 
evidence for shared mechanisms." Psychol Sci 20(9): 1118-24. 
 
 
                                                 
i Reprinted from Journal of Pediatric Nursing, Vol 15, Bender, Patricia L, Genetics of 
cleft lip and palate, Pages No. 242-249, Copyright 2000, with permission from Elsevier  
ii Reprinted from The Lancet, Vol 374, Mossey, P. A., J. Little, et al., Cleft lip and palate, 
Pages 1773-1785 Copyright 2009,  with permission from Elsevier.  
iii Reprinted from Cell, Vol 116, Reed, Randal R., After the Holy Grail: Establishing a 
Molecular Basis for Mammalian Olfaction, Pages 329-336, Copyright 2004, with permission 
from Elsevier. 
